A percentage of newly diagnosed patients had disease with lower genomic instability.
The study is a collaboration of pediatric, adult cooperative groups.
Study results differ from prior research into microRNAs as predictive biomarkers.
Pregnancy was not linked to differences in survival outcomes.
Although parking is free at some centers, costs at others can be hundreds of dollars.
Regardless of the efficacy of immune checkpoint inhibition in some settings, many cancers will not respond to treatment with them.
Some tyrosine kinase inhibitors may cause a hyperinflammatory response.
Patients initially given pembrolizumab had longer PFS even after subsequent therapy.
A proof-of-principle study confirms presence of TP53 variants ahead of diagnosis.
A small percentage of patients with NSCLC could stand to benefit from tepotinib.
